Clinical Updates

New data suggests the erectile dysfunction (ED) drug Cialis may also be beneficial in helping men who have problems… »   

Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for… »   

Eli Lilly and Co’s stomach cancer drug ramucirumab met its primary goal of improving overall survival in a late stage-study,… »   

Johnson & Johnson may sell or spin off its slow-growing $2 billion-a-year diagnostics business, the company said on Tuesday when… »   

Novartis expects sales to grow in the mid-single digits from 2014 once it has absorbed the full impact of competition… »   

Creditors of the bankrupt pharmacy linked to a deadly U.S. meningitis outbreak are investigating $16 million in salary and shareholder… »   

Psychiatrists who are exposed to conflict-of-interest (COI) policies during their residency are less likely to prescribe brand-name antidepressants after graduation… »   

AstraZeneca’s new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and… »   

A new study has found that tamoxifen, a well-known breast cancer drug, can counteract some pathologic features in a… »   

In what is likely to come as little surprise, a U.S. study has found that patients and their families are… »   

Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells… »   

French health authorities will ask the European Union to restrict the use of newer types of contraceptive pills over concerns… »   

If you’ve spent years CRANKING YOUR MUSIC UP TO 11, this item’s for you.

A drug developed for Alzheimer’s disease… »   

U.S. regulators proposed new food safety rules on Friday that aim to make food processors and farms more accountable for… »   

Side effects are a major reason that drugs are taken off the market and a major reason why patients stop… »